Business Description
Bellevue Life Sciences Acquisition Corp
NAICS : 551112
SIC : 6719
ISIN : US0791741087
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.79 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.74 | |||||
9-Day RSI | 48.73 | |||||
14-Day RSI | 49.93 | |||||
6-1 Month Momentum % | 3.44 | |||||
12-1 Month Momentum % | 6.3 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 36.47 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -1.45 | |||||
ROA % | -1.26 | |||||
ROIC % | -28.43 | |||||
ROCE % | -6.43 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.05 | |||||
Price-to-Tangible-Book | 3.05 | |||||
EV-to-EBIT | -21.09 | |||||
EV-to-EBITDA | -21.09 | |||||
EV-to-FCF | -24.09 | |||||
Earnings Yield (Greenblatt) % | -4.74 | |||||
FCF Yield % | -4.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BLAC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bellevue Life Sciences Acquisition Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.1 | ||
Beta | 0 | ||
Volatility % | 1.56 | ||
14-Day RSI | 49.93 | ||
14-Day ATR ($) | 0.228917 | ||
20-Day SMA ($) | 11.26211 | ||
12-1 Month Momentum % | 6.3 | ||
52-Week Range ($) | 10.47 - 13.4 | ||
Shares Outstanding (Mil) | 4.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bellevue Life Sciences Acquisition Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bellevue Life Sciences Acquisition Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Bellevue Life Sciences Acquisition Corp Frequently Asked Questions
What is Bellevue Life Sciences Acquisition Corp(BLAC)'s stock price today?
When is next earnings date of Bellevue Life Sciences Acquisition Corp(BLAC)?
Does Bellevue Life Sciences Acquisition Corp(BLAC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |